NCT05910333 is a clinical trial of observation in Bone Resorption, sponsored by Mohamed Elsawy.

Who is sponsoring NCT05910333?

NCT05910333 is sponsored by Mohamed Elsawy.

What drugs are being tested in NCT05910333?

Interventions in NCT05910333: observation.

What condition does NCT05910333 study?

NCT05910333 studies Bone Resorption.

Is NCT05910333 still recruiting?

NCT05910333 is currently status unknown. Last updated 23 October 2023.

Last reviewed 2023-10-23 · How we verify

NCT05910333

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Four Locator Attachment Mandibular Overdentures

Status unknown Last updated 23 October 2023

What this trial tests

trial testing observation in Bone Resorption in 20 participants. Status unknown.

Timeline

28 March 2023

Primary endpoint
21 October 2023

27 October 2023

Quick facts

Lead sponsor	Mohamed Elsawy
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	28 March 2023
Primary completion	21 October 2023
Estimated completion	27 October 2023
Sites	1 location across Egypt

Drugs / interventions tested

observation

Conditions studied

Bone Resorption — all drugs for Bone Resorption →

Sponsor

Mohamed Elsawy

Who can join

Adults 55 to 80, any sex, with Bone Resorption. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

. There is little information on the degree of crestal bone loss around 4 inter-foraminal implant-retained mandibular overdentures (OVDs) and the amount of bone remodelling on the anterior maxilla and posterior mandibule on long-term function, particularly with different distributions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of observation

Trials testing the same drug.

NCT06493448 — Prospective Observational Cohort Study · not yet recruiting
NCT06432153 — Tampa Scale of Kinesiophobia for Heart Taiwan Version Validation · not yet recruiting
NCT06491966 — Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis · recruiting
NCT06327165 — Predictability of ANI (Analgesia Nociception Index) for Spinal Hypotension · unknown
NCT06114446 — The Evaluation of the Effectiveness of Nursing Care Education Provided With Immersive Virtual Reality · NA · completed

Other recruiting trials for Bone Resorption

Currently open trials in the same condition.

NCT07080710 — State of the Art Immediate Implant Placement in the Premaxilla · NA · recruiting
NCT06820489 — Comparison of Three Transmucosal Augmentation Techniques in Immediate Implant Placement · NA · recruiting
NCT06679283 — Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF) · NA · recruiting
NCT06764654 — Randomized Clinical Study Comparing Two Guided Surgery Techniques for Free-end Implant Placement · NA · recruiting
NCT05772364 — High- Versus Low-calcium Water for Bone Health · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05910333 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mohamed Elsawy
Last refreshed: 23 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05910333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing